Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Acute Heart Failure
NCT07403955Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Randomised trial of dapagliflozin in Acute Heart Failure (AHF) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Left ventricular global longitudinal strain at 3 months. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT07403955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07403955.